ArticleBritish journal of cancer2016

Long-term acquired everolimus resistance in pancreatic neuroendocrine tumours can be overcome with novel PI3K-AKT-mTOR inhibitors.

Timon Vandamme et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.